🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Treatment Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to contact these accounts directly for source information, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Experts Voice Concerns

However, physicians and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in individuals injecting products of uncertain source.

Several professionals said the popularity for retatrutide could be connected to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, prosecution or prison.

Service Reaction and Content Removal

According to the social media company, the platform has removed problematic content and banned associated keywords and query recommendations. The company said it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Investigations also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, filled with images of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.

After minutes of entering one group, a vendor posted contact information, where the majority of transactions take place. The vendor sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, medical conditions or past usage.

Item Information and Costs

Inside these communities, messages show black plastic packages with postal service stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually sold at £160 for 20mg. When asked how long a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram stated it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these digital products may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered individuals injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject users to potentially significant health risks”.